PHASE II STUDY OF AMRUBICIN (AMR) COMBINED WITH CARBOPLATIN (CBDCA) FOR ELDERLY PATIENTS WITH SMALL CELL LUNG CANCER (SCLC). (NORTH JAPAN LUNG CANCER GROUP 0405)

被引：0
|
作者：
Nakamura, A. [1 ]
Sugawara, S. [2 ]
Harada, M. [3 ]
Usui, K. [4 ]
Suzuki, T. [5 ]
Yokouchi, H. [6 ]
Maemondo, M. [7 ]
Nukiwa, T. [8 ]
Inoue, A. [1 ]
机构：
[1] Tohoku Univ Hosp, Sendai, Miyagi, Japan
[2] Sendai Kosei Hosp, Dept Resp Med, Sendai, Miyagi, Japan
[3] Hokkaido Canc Ctr, Dept Resp Med, Sapporo, Hokkaido, Japan
[4] Kanto Med Ctr NTT EC, Dept Resp Med, Tokyo, Japan
[5] Isawa Hosp, Dept Resp Med, Oshu, Japan
[6] Iwamizawa Rosai Hosp, Dept Resp Med, Iwamizawa, Japan
[7] Miyagi Canc Ctr, Dept Resp Med, Natori, Miyagi 9811293, Japan
[8] Tohoku Univ, Dept Resp Oncol & Mol Med, Inst Dev Aging & Cancer, Sendai, Miyagi 980, Japan
来源：
ANNALS OF ONCOLOGY | 2008年 / 19卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：117 / 118
页数：2
相关论文
共 50 条
  • [31] RESULTS OF A RANDOMIZED PHASE III STUDY OF SINGLE-AGENT AMRUBICIN (AMR) VERSUS CARBOPLATIN AND ETOPOSIDE (CE) IN ELDERLY PATIENTS WITH EXTENSIVE-DISEASE SMALL CELL LUNG CANCER (ED-SCLC)
    Hida, N.
    Okamoto, H.
    Horai, T.
    Nakagawa, K.
    Nishiwaki, Y.
    Yokoyama, A.
    Katakami, N.
    Shibuya, M.
    Saijo, N.
    Fukuoka, M.
    ANNALS OF ONCOLOGY, 2010, 21 : 148 - 148
  • [32] A phase II study of weekly docetaxel combined with carboplatin for elderly patients with advanced non-small cell lung cancer
    Son, C.
    Kim, K.
    Lee, K.
    Yang, D.
    Lee, S.
    Choi, P.
    Cho, S.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [33] A phase II study of weekly paclitaxel combined with carboplatin for elderly patients with advanced non-small cell lung cancer
    Inoue, A
    Usui, K
    Ishimoto, O
    Matsubara, N
    Tanaka, M
    Kanbe, M
    Gomi, K
    Koinumaru, S
    Saijo, Y
    Nukiwa, T
    LUNG CANCER, 2006, 52 (01) : 83 - 87
  • [34] Phase II study of irinotecan and amrubicin in patients with relapsed non-small cell lung cancer: Okayama Lung Cancer Study Group Trial 0402
    Nogami, Naoyuki
    Hotta, Katsuyuki
    Segawa, Yoshihiko
    Takigawa, Nagio
    Hosokawa, Shinobu
    Oze, Isao
    Fujii, Masanori
    Ichihara, Eiki
    Shibayama, Takuo
    Tada, Atsuhiko
    Hamada, Noboru
    Uno, Masatoshi
    Tamaoki, Akihiko
    Kuyama, Shoichi
    Ikeda, Genyo
    Osawa, Masahiro
    Takata, Saburo
    Tabata, Masahiro
    Tanimoto, Mitsune
    Kiura, Katsuyuki
    ACTA ONCOLOGICA, 2012, 51 (06) : 768 - 773
  • [35] Etoposide phosphate with carboplatin in the treatment of elderly patients with small-cell lung cancer:: A phase II study
    Quoix, E
    Breton, JL
    Daniel, C
    Jacoulet, P
    Debieuvre, D
    Paillot, N
    Kessler, R
    Moreau, L
    Coëtmeur, D
    Lemarié, E
    Milleron, B
    ANNALS OF ONCOLOGY, 2001, 12 (07) : 957 - 962
  • [36] Phase II Study of Docetaxel and Carboplatin in Elderly Patients with Advanced Non-small Cell Lung Cancer
    Yoshimura, Naruo
    Kudoh, Shinzoh
    Kimura, Tatsuo
    Mitsuoka, Shigeki
    Kyoh, Shigenoir
    Tochino, Yoshihiro
    Asai, Kazuhisa
    Kodama, Toyoki
    Ichimaru, Yukikazu
    Yana, Takashi
    Hirata, Kazuto
    JOURNAL OF THORACIC ONCOLOGY, 2009, 4 (03) : 371 - 375
  • [37] A phase II study of irinotecan (CPT-11) and carboplatin in patients with limited disease small cell lung cancer (SCLC)
    Laack, Eckart
    Thoem, Ina
    Kruell, Andreas
    Engel-Riedel, Walburga
    Mueller, Thomas
    Meissner, Christoph
    Duerk, Heinz
    Fischer, Juergen
    Guetz, Sylvia
    Kortsik, Cornelius
    Elbers, Matthias
    Schuch, Gunter
    Andritzkya, Birte
    Goern, Michael
    Burkholder, Iris
    Edler, Lutz
    Hossfeld, Dieter Kurt
    Bokemeyer, Carsten
    LUNG CANCER, 2007, 57 (02) : 181 - 186
  • [38] Phase II study of carboplatin and irinotecan (CPT-11) in patients with limited disease small cell lung cancer (SCLC)
    Laack, E.
    Boeters, I.
    Kruell, A.
    Engel-Riedel, W.
    Mueller, T.
    Meibner, R.
    Duerk, H.
    Burkholder, I.
    Hossfeld, D. K.
    Bokemeyer, C.
    EJC SUPPLEMENTS, 2005, 3 (02): : 328 - 328
  • [39] DOCETAXEL-CARBOPLATIN (DC) AS SECOND LINE TREATMENT IN PATIENTS WITH SMALL CELL LUNG CANCER (SCLC): A PHASE II STUDY
    Van Riel, Sunit
    Schramel, Franz M. N. H.
    Smit, Hans J. M.
    Van Walree, Nico C.
    Groen, Harry J. M.
    Schreurs, Ad J. M.
    Biesma, Bonne
    JOURNAL OF THORACIC ONCOLOGY, 2013, 8 : S1231 - S1231
  • [40] Weekly carboplatin and paclitaxel in elderly Non-small-cell lung cancer patients (≥65 years of age) -: A phase II North Central Cancer Treatment Group Study
    Jatoi, A
    Stella, PJ
    Hillman, S
    Mailliard, JA
    Vanone, S
    Perez, EA
    Cannon, MW
    Geyer, S
    Wiesenfeld, M
    Jett, JR
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2003, 26 (05): : 441 - 447
12345